Introduction
domain contains a varying number of leucine-rich repeat domains, which are presumably involved in ligand binding but were also implicated in TLR dimerization. Ligands of the TLR include exogenous microbial components such as triacylated lipopeptides (TLR1/2), diacylated lipopeptides (TLR2/6), lipopolysaccharide (LPS) (TLR4) and flagellin (TLR5)
. The antiviral TLRs are TLR3 which recognizes dsRNA, TLR7 and TLR8 which both bind to ssRNA, and TLR9 which recognizes CpG motifs that exist in both virus and bacteria [14] . The most recently identified TLR10 is an orphan member of the TLR family [15] . [16] [17] [18] . These [17] , stimulation of human bone marrow derived MSCs with a TLR agonist resulted in increased proliferation [18] . [16] . [19] . These cells have a large potential to develop into the classical MSC lineages, such as osteoblasts, chondrocytes and adipocytes but in addition into haematopoietic cells, liver, and neural and heart tissue [19, 20] . Since MSC undergo a decline in differentiation and proliferation capacity in time, it is to be expected that MSC isolated from UCB represent an earlier cell type and therefore posses improved capacities [21, 22] 
Besides their important function on immune cells, TLR triggering on mesenchymal stem cells (MSCs) from different origins was recently described

Furthermore, differences in (spontaneous) differentiation were observed for both types of stem cells. TLR stimulation on MSCs drive their migration and immunomodulatory responses
Unstable immunosuppressive properties due to TLR activation is of importance when MSCs are used to treat steroid resistant graft versus host disease. Recently, a new pluripotent population of umbilical cord blood (UCB) cells, termed unrestricted somatic stem cells (USSCs), was identified
. Like MSCs, USSCs are able to inhibit dendritic cell (DC)-induced T-cell proliferation, endowing them with an important regulatory role in the immune system. In addition, a recent paper describes the clinical potential for using USSCs in facilitating homing and engraftment of CD34
ϩ cells in haematopoietic stem cell transplantation [23] . 
Materials and methods
Generation and expansion of USSCs
USSCs were successfully generated according to Kögler et al. [19] 
TLR expression in USSCs
PCR primers specific for TLR1 to TLR10 were designed to detect TLRs from total RNA in USSCs (Fig. 1a) 
Cytokine expression assay
USSCs were cultured for 24 hrs with various TLR agonists and total RNA was isolated. TLR agonists were used at the same concentrations as described above.
Th1 (IL-2, IFN-␥, TNF-␣) and Th2 cytokines (IL-4, IL-5 and IL-10) were quantified with a Th1/Th2 cytokine kit (BD Biosciences). IL-1, IL-6, IL-8 and IL-12 were determined by ELISA (R&D Systems, Minneapolis, MN, USA).
Bisulphite modification of genomic DNA
Bisulphite treatment was used to convert unmethylated cytosine residues in genomic DNA to uracil. Genomic DNA was digested with EcoRI and DNA was purified and resuspended in TE. The DNA was added to a solution containing sodium bisulphite and hydroquinone. The DNA was purified with the NucleoSpin® Extract II kit (Macherey-Nagel, Düren, Germany).
Methylation-specific restriction polymerase chain reaction
Methylation-specific primers that flank the critical nuclear factor and activator of T cells (NFAT) binding 3 binding site within the TNF promoter were designed (http://www.urogene.org/methprimer/) [26] . Forward primer 5Ј GTGTGTTTTTAATTTTTTAAATTTT 3Ј and reverse primer 5Ј CAAC-TACCTTTATATATCCCTAAAAC 3Ј [27] . 
Generation of monocyte derived DCs and mixed lymphocyte reaction (MLR)
DC generation and MLR were performed as described elsewhere [28] (Fig. 1c) . [29] . In order to investigate whether TLRs, expressed on USSCs, are functional, the outcome of TLR agonists-mediated TLR activation was performed with NF-B localization as a read-out. USSCs were stimulated with various agonists and NF-B localization was assayed in time using immunofluorescence and subsequent CSLM. As shown in Fig. 2 30 or 120 min., respectively. The response to flagellin was still present at 60 min. but faded thereafter (Fig. 2b) . The response to LPS persisted up to at least 240 min. (Fig. 2a) (Fig. 4a) . Endogenously produced VEGF and TGF-␤ was unaffected after LPS and flagellin stimulation (Fig. 4d) .
TLR ligands induce NF-B nuclear translocation
In immune cells, TLR activation induces nuclear translocation of NF-B from the cell cytosol, resulting in NF-B-dependent gene expression
, flagellin (TLR5) and LPS-(TLR4) induced NF-B translocation to the nucleus within
In addition, we analysed cytokine expression in conditioned media from USSCs following culture with both TLR agonists using Fig. 4c , PDTC significantly decreased the production of IL-8 in a dosedependent manner. (Fig. 5a, and [30] [31] [32] (Fig. 5a) . Fig. 5a ), indicating the presence of methylated cytosine residues. (Fig. 6a and (Fig. 6a) . The levels of induction did not change upon pre-stimulation of USSCs with either LPS or flagellin (Fig. 6a) (Fig. 6b) . [19, 20] pathway is the osteoblastic lineage. Therefore, TLR agonists were added to the differentiation media to assess whether TLR agonists affect the osteogenic differentiation of USSCs. Cells were differentiated for 6 to 14 days and osteogenic differentiation was detected by ALP or ARS staining. LPS and flagellin strongly stimulated the initial phase of osteogenic differentiation of USSCs as compared to the normal control. As a negative control polyI: C was used (Fig. 7) , since this TLR agonist had no effect on NF-B signalling, proliferation and immunomodulatory properties.
, respectively, as analysed by confocal microscopy using an anti-NF-B antibody. Stimulation with all other agonists did not result in NF-B nuclear translocation. a human IL-1, IL-6, IL-8 and IL-12 ELISA. In accordance with mRNA expression data we observed up-regulation of IL-6 and IL-8 levels after 4 hrs of LPS stimulation which lasted at least 24 hrs (Fig. 4b). Interestingly, we observed no significant change in IL-1 and IL-12 expression (data not shown). When the TLR5 agonist flagellin was used, a small but significant increase in IL-8 expression was observed while expression levels of IL-6 did not significantly change (Fig. 4b). To support the fact that other TLR agonists did not lead to NF-B translocation we also analysed IL-8 production upon TLR stimulation using Pam3Cys, polyI: C, FSL-1, R848, and CpG. Stimulation with these agonists did not result in increased IL-8 production (data not shown), confirming that these TLRs are not expressed on USSCs. In addition, the level of other cytokines using the CBA measurement kit was measured. We found that upon stimulation of USSCs with the different TLR agonists no expression of IL-10, TNF-␣ and IFN-␥ was observed (data not shown). To examine the role of NF-B activation for augmented production of IL-8 in USSCs stimulated with LPS, PDTC, a known NF-B inhibitor, was added to USSC cultures. As shown in
The TNF promoter is methylated in USSCs
As both quantitative and conventional RT-PCR failed to demonstrate any TNF-␣ expression at the mRNA level in USSCs
. This region, which lies ~200 bp upstream of the transcription start site of the TNF-␣ gene, contains a so-called 3 site, which has recently been demonstrated to bind to the transcription factor NFAT [27]. First, the expression of TNF-␣ was assessed by RT-PCR in myeloid cells with TNF-␣-specific, intron-spanning primers. Monocytes as well as immature, mature and tolerogenic DCs express TNF-␣ at the mRNA level, whereas USSCs do not (Fig. 5a). Next, bisulphite-treated genomic DNA from immature DCs was amplified with methylation-specific primers and appeared to be resistant to the restriction enzyme TaqI, indicating that the TNF-␣ promoter in immature dendritic cells (imDCs) is not methylated, and therefore is active in these cells
Intriguingly, when bisulphite-treated genomic DNA from two different USSC donors was amplified and digested with TaqI, the majority of full-length PCR products of 183 bp was digested into two fragments of 141 and 42 bp, respectively (see arrows,
Importantly, this was irrespective of 2-hr stimulation with either LPS or flagellin. Together, these data indicate that TNF-␣ is not expressed in USSCs as a result of the methylation of its promoter.
TLR agonists do not affect the alloresponse against USSCs
Another feature that could be affected by TLR agonists is the immunomodulatory response of USSCs. Therefore, MLRs were performed. T cells, when cultured alone, show basal proliferation activity which is highly increased when T cells are co-cultured with allogeneic imDCs
b). When T cells were co-cultured with unstimulated USSCs moderate induction of T-cell proliferation is observed
or any of the other TLR agonists (data not shown). In addition, USSCs inhibited imDC-induced T-cell proliferation (Fig. 6b). Stimulation of USSCs with either LPS or flagellin prior to co-culture with PBLs and imDCs did not influence this immunomodulatory effect
TLR4 engagement enhances the osteogenic differentiation kinetics of USSCs
USSCs have the ability to differentiate into several lineages, such as osteoblasts, chondrocytes, adipocytes, haematopoietic cells, liver and neural and heart tissue
After day 11 of differentiation no difference in osteogenic differentiation was observed (data not shown). Additionally, USSCs cultured in normal USSC medium stained negative for both ALP and ARS (data not shown).
Identical results were found for both USSC lines. [33, 34] [17, 18] 
Discussion
Initially, research on TLRs focused on their expression and signalling consequences in immune cells
, no effect of TLR stimulation on the proliferation of USSCs was observed. Regarding differentiation, treatment of MSCs with certain TLR agonists
Fig. 5 The TNF␣ promoter is methylated in USSCs. (A) TNF␣ mRNA was detected by means of non-quantitative RT-PCR in monocytes (Mono), immature DC (imDC), DC stimulated with LPS for 6 hrs (DC, 6-hr LPS), tolerogenic DC (tolDC), tolerogenic DC stimulated with LPS for 6 hrs (tolDC, 6-hr LPS) and USSCs from donor 5016 (USSC-5016). The promoter of TNF␣ in imDC appeared to be unmethylated, as demonstrated by the resistance of methylation-specific genomic PCR products to TaqI digestion. (B) The TNF-␣ promoter in USSCs from two different donors (USSC-5016 and -DD) is methylated, as methylation-specific genomic
Fig. 6 TLR agonists do not affect immunosuppressive activity of USSCs. After 6 days of culturing PBLs alone they exhibited only baseline proliferation as measured by 3H-thymidine incorporation (counts per minute) (A and Bb; first bar). Responder PBLs co-cultured with allogeneic imDCs exhibited marked increase in proliferation (A and B; second bar). Responder PBLs co-cultured with USSCs exhibited average proliferation (A; third bar). Stimulation of USSCs with various TLR agonists did not result in changes in T-cell proliferation (A; right bars). When PBLs stimulated with imDCs were co-cultured with USSCs proliferation is inhibited independent of TLR stimulation prior to co-culture (B; right bars). *ϭ significantly different from PBL ϩ DC cultures, **ϭ significantly different from all other co-cultures (P Ͻ 0.001).
inhibited differentiation into osteogenic, adipogenic and chondrogenic cells [18] . Additionally, LPS-treated embryoid bodies failed to differentiate into functional osteoblasts [37] , whereas LPS-treated hADSC showed increased osteogenic differentiation [17] . Here 
